RSMDF
RESMED INC
Key Financials
Revenue
$5.1B
↑ 9.8%
Gross Profit
$3.1B
↑ 15.1%
Net Income
$1.4B
↑ 37.2%
Operating Income
$1.7B
↑ 27.7%
EPS (Diluted)
$9.51
↑ 37.4%
Total Assets
$8.2B
↑ 18.9%
Total Liabilities
$2.2B
↑ 9.9%
Shareholders' Equity
$6.0B
↑ 22.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 5/11/2026 | View on SEC |
| 144 | 5/7/2026 | View on SEC |
| 3 | 5/4/2026 | View on SEC |
| 4 | 5/4/2026 | View on SEC |
| 10-Q | 5/1/2026 | View on SEC |
| 8-K | 4/30/2026 | View on SEC |
| 8-K | 4/30/2026 | View on SEC |
| SCHEDULE 13G | 4/29/2026 | View on SEC |
| SCHEDULE 13G | 4/29/2026 | View on SEC |
| 4 | 4/9/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | RSMDF |
| Company Name | RESMED INC |
| CIK | 943819 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Large accelerated filer |
| Exchange | NYSE |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 0630 |
| State of Incorporation | DE |
| Phone | 8587462400 |